Infectious Diseases News and Research

RSS

Nexera to submit amended claims for FDA 510(k) clearance of SpectraShield 9500 Surgical N95 Respirator

Nexera Medical, Inc., today announced plans to submit to the U.S. Food and Drug Administration amended antimicrobial claims for its current 510(k) clearance for the SpectraShield 9500 Surgical N95 Respirator with embedded antimicrobial technology. The expanded antimicrobial claims will be supported by test data on the inactivation performance of certain strains of viruses.

8 Sep 2011

Mass. Eye and Ear receives NIAID grant to coordinate Harvard-wide Project on Antibiotic Resistance

The Massachusetts Eye and Ear Infirmary has received an $11 million grant from the National Institute of Allergy and Infectious Disease, the largest National Institutes of Health grant in this hospital's187-year history, to coordinate the Harvard-wide Project on Antibiotic Resistance.

8 Sep 2011

UC Merced, UCSF to examine effectiveness of state and local antismoking programs

Researchers with the University of California, San Francisco, and UC Merced will examine the effectiveness of state and local antismoking programs across the United States in an effort to make sure health authorities are able to use their increasingly limited resources to support and defend the most effective approaches.

8 Sep 2011

U.N. declares famine in sixth region of Somalia, expresses concern over spread of disease

The U.N. "announced Monday that Somalia's famine had spread to a sixth area within the country, with officials warning that 750,000 people could die in the next few months unless aid efforts were scaled up," the New York Times reports.

7 Sep 2011

Genetically modified M. smegmatis vaccine shows promise against TB

An experimental vaccine composed of a genetically modified bacterium closely related to the bacterium that causes tuberculosis (TB) has been found to protect mice against TB infection, according to a study appearing online September 4 in the journal Nature Medicine.

7 Sep 2011

Teenagers use medicines frequently without receiving targeted information about risks and benefits

A large proportion of teenagers regularly and frequently take some form of medication without receiving targeted information about the risks and benefits, according to a review of current research, to be presented at the annual congress of the International Pharmaceutical Federation.

5 Sep 2011

IKEPLUS immunization completely eliminates TB bacteria from infected tissues

A potential vaccine against tuberculosis has been found to completely eliminate tuberculosis bacteria from infected tissues in some mice. The vaccine was created with a strain of bacteria that, due to the absence of a few genes, are unable to avoid its host's first-line immune response.

5 Sep 2011

Researchers inject cultured red blood cells created from HSCs into human donor

For the first time, researchers have successfully injected cultured red blood cells (cRBCs) created from human hematopoietic stem cells (HSCs) into a human donor, according to study results published today in Blood, the Journal of the American Society of Hematology.

3 Sep 2011

In research world, Walter Reed fights malaria while new facility seeks to prevent medical errors

Most people know "the Walter Reed" as a mammoth military medical center in Washington, D.C., where both U.S. presidents and ordinary war-wounded soldiers get their care. But the center's Walter Reed Army Institute of Research, housed for the past decade on its own campus in Maryland, just outside Washington, is one of the world's premier research centers for infectious diseases.

3 Sep 2011

Plerixafor drug shows promise against WHIM syndrome

A new study reports that a drug already approved by the Food and Drug Administration for use in patients undergoing a bone marrow transplant may also have promise for treating people who have a rare immune deficiency known as WHIM syndrome.

3 Sep 2011

NPR examines legacy of Walter Reed Army Medical Center's Institute of Research in battle against malaria

"As the Walter Reed Army Medical Center decamps from its D.C. campus this month and merges with the Bethesda Naval Hospital five miles away," NPR reports on the legacy of "the center's Walter Reed Army Institute of Research, housed for the past decade on its own campus in Maryland, just outside Washington, as one of the world's premier research centers for infectious diseases."

3 Sep 2011

First Edition: September 2, 2011

On Kaiser Health News' blog, staff writer Julie Appleby writes: "Insurers who offer 'association health plans,' which are often sold through trade groups or other organizations of affiliated members, will face the same scrutiny of premium rate hikes as other types of insurance, federal officials said Thursday."

2 Sep 2011

New IDSA/PIDS guidelines can thwart pneumonia in children

Immunizations, including a yearly flu vaccine, are the best way to protect children from life-threatening pneumonia, according to new guidelines from the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America.

2 Sep 2011

Special journal edition chronicles 3-D structures of important antibacterial, bioterrorist targets

The September issue of the online scientific journal Acta Crystallographica: Structural Biology and Crystallization Communications (Acta Cryst F) will consist entirely of work done at the Seattle Structural Genomics Center for Infectious Disease (SSGCID), a consortium of researchers from Seattle BioMed, Emerald BioStructures, the University of Washington and Pacific Northwest National Laboratory.

2 Sep 2011

Tamiflu resistant flu found in Newcastle, Australia

The influenza pandemic has gathered a lot of action, advice and coverage over the last few years. In 2009, an international H1N1 influenza pandemic led to concerns that there would be a repeat of the 1918 influenza pandemic which resulted in millions of deaths worldwide. The World Health Organization recorded over 37,000 cases of the H1N1 pandemic influenza in Australia and 193 confirmed deaths.

2 Sep 2011

MRSA ‘superbug’: Everyone at risk!

Methicillin-resistant Staphylococcus aureus (MRSA), a type of staph bacteria that does not respond to commonly used antibiotic treatments, is a type of infection that has been a problem in hospital settings for many years. Back in 2000 it began steadily making its way into the lives of otherwise healthy people, especially children, who are not typically at risk for the fast-moving bacteria.

2 Sep 2011

Medivir completes enrollment of three TMC435 phase 3 trials on CHC genotype-1 infection

MedivirAB is an emerging researchbased specialty pharmaceutical company focused on infectious diseases. Medivir today announced that its investigational protease inhibitor TMC435, developed by Tibotec Pharmaceuticals, has successfully completed enrollment of three ongoing global phase 3 trials and further reports that all patients are now on TMC435 or active control treatment.

31 Aug 2011

Infant rotavirus vaccination may provide indirect protection to older children, adults in the U.S.

Vaccinating infants against rotavirus also prevents serious disease in unvaccinated older children and adults, according to a study by the Centers for Disease Control and Prevention.

31 Aug 2011

SAIC awards Selecta a subcontract to develop synthetic nanoparticle vaccine for malaria

Selecta Biosciences, Inc., a biopharmaceutical company developing an entirely new class of targeted vaccines and immunotherapies, today announced that Science Applications International Corporation (SAIC) has awarded Selecta a subcontract to develop a targeted synthetic vaccine particle product for malaria.

31 Aug 2011

Medivir reports net sales of SEK 444.6 m for 1 January - 30 June 2011

Medivir: Interim period (January 2011 - June 2011). Net sales were SEK 444.6 (35.7) m.

31 Aug 2011

Infectious Diseases News and Research

Nexera to submit amended claims for FDA 510(k) clearance of SpectraShield 9500 Surgical N95 Respirator

Mass. Eye and Ear receives NIAID grant to coordinate Harvard-wide Project on Antibiotic Resistance

UC Merced, UCSF to examine effectiveness of state and local antismoking programs

U.N. declares famine in sixth region of Somalia, expresses concern over spread of disease

Genetically modified M. smegmatis vaccine shows promise against TB

Teenagers use medicines frequently without receiving targeted information about risks and benefits

IKEPLUS immunization completely eliminates TB bacteria from infected tissues

Researchers inject cultured red blood cells created from HSCs into human donor

In research world, Walter Reed fights malaria while new facility seeks to prevent medical errors

Plerixafor drug shows promise against WHIM syndrome

NPR examines legacy of Walter Reed Army Medical Center's Institute of Research in battle against malaria

First Edition: September 2, 2011

New IDSA/PIDS guidelines can thwart pneumonia in children

Special journal edition chronicles 3-D structures of important antibacterial, bioterrorist targets

Tamiflu resistant flu found in Newcastle, Australia

MRSA ‘superbug’: Everyone at risk!

Medivir completes enrollment of three TMC435 phase 3 trials on CHC genotype-1 infection

Infant rotavirus vaccination may provide indirect protection to older children, adults in the U.S.

SAIC awards Selecta a subcontract to develop synthetic nanoparticle vaccine for malaria

Medivir reports net sales of SEK 444.6 m for 1 January - 30 June 2011

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News